The following is excerpted from the question-and-answer section of the transcript.
(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)
Question: Guyn Kim - Water Tower Research - Analyst
: Hi Kirk and Brad. Congrats on the progress and thanks for taking my questions. The first one I have on the Rebis alliance. We understand that with
the new marketing model, you have the potential to generate higher margin revenue. But could you help us know what the incentive for Rebis
here is in this collaboration?
REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us
consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies.
MARCH 31, 2025 / 9:00PM, VVOS.OQ - Q4 2024 Vivos Therapeutics Inc Earnings Call
Question: Guyn Kim - Water Tower Research - Analyst
: Yes. It sounds like a perfect match right in your backyard. You also talked about repurposing your medical integration division into an M&A team.
I was hoping you could expand a little bit more on that. And if you're able to talk about what regions that they're deployed in and whether certain
territories are focused and what you hope to gain from this whole transition?
Question: Scott Henry - Alliance Global Partners - Analyst
: A couple of questions. First, and I know you have a lot of moving parts with the changing business model. But any thoughts on how we should
think of 2025 relative to 2024 as far as top line revenues and even perhaps a little easier, the sequential change from fourth quarter to first quarter
since today is the last day of the first quarter.
Question: Scott Henry - Alliance Global Partners - Analyst
: Okay. Great. And the income statement is changing with the new business model. So if a patient comes in and you expect to get $4,500 of revenue
from that patient, how does that $4,500 work through the income statement? I mean, does it go under appliances? Where does it come through
the income statement and in what fashion?
Question: Scott Henry - Alliance Global Partners - Analyst
: I did get a chance to look at the 10-K, which you have to back out fourth quarter. So if you changed any of the previous quarters, that may create
some noise. But when I backed out in the fourth quarter, it looked like there was a huge bolus of arches coming through, like 10,000 of the 16,000
all came in the fourth quarter. Am I doing that math correctly? Or is there a reason why that all showed up in the fourth quarter?
Question: Scott Henry - Alliance Global Partners - Analyst
: So when you booked all of that in the fourth quarter of this year, does that cover prior periods? Or could that signal -- if your biggest customer
orders -- that's a pretty big order, may they not order for a couple of quarters? Or is this backward looking?
Question: Scott Henry - Alliance Global Partners - Analyst
: Okay. That's great. And final question, Brad. Just a couple of other numbers that just kind of bounced around this quarter, but it looked like a sponsor
seminar, other among the service component was about $1 million higher than it typically is for a quarter. And it looked like VIP was actually a
negative number for the quarter. Anything to take from those trends that will be helpful going forward? Or would you just put that in the noise
category?
Question: Lucas Ward - Ascendiant Capital Markets - Analyst
: My first question is about -- so the conversion of new customers at these sleep centers, starting with Rebis, like you've described some very large
volume opportunities there, 100,000 existing customers, 1,000-plus people a month coming in to get new diagnosis. So I guess my question is
what gates the speed at which you can turn that potential customer base into Vivos customers?
Question: Lucas Ward - Ascendiant Capital Markets - Analyst
: Okay. So does this mean then that you're working with dentists that are not VIPs to get the prescriptions filled for people? Help me understand
the sales funnel a little bit better for Rebis like someone gets a diagnosis, they are presented Vivos as an option. What are the steps that they would
then go through to actually (multiple speakers).
Question: Lucas Ward - Ascendiant Capital Markets - Analyst
: Okay. Final question on M&A. It sounds like you are looking potentially to acquire sleep centers. I'm just wondering like, what would be the scale
of that type of acquisition? And how would it change your patient conversion rates or economics to own a sleep center as opposed to being an
affiliate or a partner or provider in one?
| 
